1. Home
  2. OPK vs EH Comparison

OPK vs EH Comparison

Compare OPK & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • EH
  • Stock Information
  • Founded
  • OPK 2007
  • EH 2014
  • Country
  • OPK United States
  • EH China
  • Employees
  • OPK N/A
  • EH N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • EH Military/Government/Technical
  • Sector
  • OPK Health Care
  • EH Industrials
  • Exchange
  • OPK Nasdaq
  • EH Nasdaq
  • Market Cap
  • OPK 1.1B
  • EH 1.2B
  • IPO Year
  • OPK 1995
  • EH 2019
  • Fundamental
  • Price
  • OPK $1.19
  • EH $16.90
  • Analyst Decision
  • OPK Buy
  • EH Strong Buy
  • Analyst Count
  • OPK 4
  • EH 3
  • Target Price
  • OPK $2.75
  • EH $24.80
  • AVG Volume (30 Days)
  • OPK 2.8M
  • EH 1.3M
  • Earning Date
  • OPK 07-31-2025
  • EH 08-21-2025
  • Dividend Yield
  • OPK N/A
  • EH N/A
  • EPS Growth
  • OPK N/A
  • EH N/A
  • EPS
  • OPK N/A
  • EH N/A
  • Revenue
  • OPK $664,029,000.00
  • EH $57,950,389.00
  • Revenue This Year
  • OPK N/A
  • EH $102.39
  • Revenue Next Year
  • OPK $6.98
  • EH $59.66
  • P/E Ratio
  • OPK N/A
  • EH N/A
  • Revenue Growth
  • OPK N/A
  • EH 167.93
  • 52 Week Low
  • OPK $1.11
  • EH $10.40
  • 52 Week High
  • OPK $2.04
  • EH $29.76
  • Technical
  • Relative Strength Index (RSI)
  • OPK 29.73
  • EH 39.07
  • Support Level
  • OPK $1.34
  • EH $19.56
  • Resistance Level
  • OPK $1.38
  • EH $20.45
  • Average True Range (ATR)
  • OPK 0.06
  • EH 0.84
  • MACD
  • OPK -0.02
  • EH -0.26
  • Stochastic Oscillator
  • OPK 23.53
  • EH 7.31

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Share on Social Networks: